Ironwood Pharma (IRWD) Misses Q3 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Ironwood Pharma (IRWD) Misses Q3 EPS by 21c

UPDATE: Credit Suisse Downgrades Ironwood Pharmaceuticals (IRWD) to Neutral

November 7, 2018 5:15 AM EST

(Updated - November 7, 2018 7:56 AM EST)

(updated to add analyst comments)

Credit Suisse analyst Vamil Divan downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Outperform to Neutral with a price target of $14.00 (from $22.00) citing disappointing updates on key product Linzess and what... More

JPMorgan Downgrades Ironwood Pharmaceuticals (IRWD) to Underweight

November 7, 2018 5:10 AM EST

JPMorgan analyst Eric Joseph downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Neutral to Underweight with a price target of $11.00 (from $20.00).

For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.

Shares of Ironwood Pharmaceuticals closed at $12.78 yesterday.

... More